Comparison of Mangafodipir Trisodium- and Ferucarbotran-Enhanced MRI for Detection and Characterization of Hepatic Metastases in Colorectal Cancer Patients
Hyoung Jung Kim1,2,
Kyoung Won Kim1,
Jae Ho Byun1,
Hyung Jin Won1,
Yong Moon Shin1,
Pyo Nyun Kim1,
Moo-Song Lee3 and
Moon-Gyu Lee1
1 Department of Radiology, University of UlsanAsan Medical Center, 388-1
Pungnap-dong, Songpa-gu, Seoul 138-736, South Korea.
2 Department of Diagnostic Radiology, Kyung Hee University Hospital, Seoul,
South Korea.
3 Department of Preventive Medicine, University of UlsanAsan Medical
Center, Seoul, South Korea.

View larger version (93K):
[in a new window]
|
Fig. 1A 60-year-old man with small hepatic metastasis from colorectal
carcinoma. T1-weighted MR image (TR/TE, 149/4.1; flip angle, 80°) shows
hypointense lesion (arrow) in hepatic segment II.
|
|

View larger version (107K):
[in a new window]
|
Fig. 1B 60-year-old man with small hepatic metastasis from colorectal
carcinoma. On T2-weighted MR image (infinite/134; flip angle, 150°),
lesion (arrow) is markedly hyperintense.
|
|

View larger version (104K):
[in a new window]
|
Fig. 1C 60-year-old man with small hepatic metastasis from colorectal
carcinoma. T1-weighted MR image (149/4.1; flip angle, 80°) taken 2 hr
after administration of mangafodipir trisodium shows hypointense lesion with
peripheral rim enhancement (arrow). Observer 1 interpreted this
lesion as probably benign and observer 2, as possibly malignant; consensus
interpretation determined this lesion to be malignant. Final histopathologic
diagnosis was metastatic mucinous adenocarcinoma from colorectal
carcinoma.
|
|

View larger version (98K):
[in a new window]
|
Fig. 2A 55-year-old man with small hepatic metastasis from colorectal
carcinoma. On T1-weighted (TR/TE, 149/4.1; flip angle, 80°) (A) and
T2-weighted (infinite/134; flip angle, 150°) (B) MR images, lesion
is not conspicuous.
|
|

View larger version (97K):
[in a new window]
|
Fig. 2B 55-year-old man with small hepatic metastasis from colorectal
carcinoma. On T1-weighted (TR/TE, 149/4.1; flip angle, 80°) (A) and
T2-weighted (infinite/134; flip angle, 150°) (B) MR images, lesion
is not conspicuous.
|
|

View larger version (93K):
[in a new window]
|
Fig. 2C 55-year-old man with small hepatic metastasis from colorectal
carcinoma. On T1-weighted dynamic-phase MR image (149/4.1; flip angle,
80°) after administration of ferucarbotran, peripheral rim enhancement
(arrow) is evident.
|
|

View larger version (110K):
[in a new window]
|
Fig. 2D 55-year-old man with small hepatic metastasis from colorectal
carcinoma. On T2*-weighted accumulation-phase image (149/10; flip
angle, 30°), lesion (arrow) is hyperintense. It was proven
histopathologically to be metastasis.
|
|

View larger version (90K):
[in a new window]
|
Fig. 3A Previous surgical site on mangafodipir trisodium-enhanced MR image
in 57-year-old man. T1-weighted MR image (TR/TE, 149/4.1; flip angle, 80°)
shows hypointense lesion (arrow) at hepatic segment IV.
|
|

View larger version (117K):
[in a new window]
|
Fig. 3B Previous surgical site on mangafodipir trisodium-enhanced MR image
in 57-year-old man. On T2-weighted MR image (infinite/134; flip angle,
150°), lesion is seen as slightly hyperintense (arrow).
|
|

View larger version (110K):
[in a new window]
|
Fig. 3C Previous surgical site on mangafodipir trisodium-enhanced MR image
in 57-year-old man. T1-weighted MR image (149/4.1; flip angle, 80°)
obtained 2 hr after mangafodipir trisodium injection shows peripheral rim
enhancement (arrow) with hypointense center. Lesion was interpreted
to be metastasis but was found to be site of previous surgery for hepatic
metastasis from colorectal carcinoma. Lesion showed no interval change on
follow-up CT 6 months later.
|
|

View larger version (100K):
[in a new window]
|
Fig. 4A Hepatic metastasis on ferucarbotran-enhanced MRI in 65-year-old man.
T1-weighted MR image (TR/TE, 149/4.1; flip angle, 80°) shows moderately
hypointense lesion (arrow).
|
|

View larger version (118K):
[in a new window]
|
Fig. 4B Hepatic metastasis on ferucarbotran-enhanced MRI in 65-year-old man.
On T2-weighted MR image (infinite/134; flip angle, 150°), lesion is seen
as slightly hyperintense (arrow).
|
|

View larger version (105K):
[in a new window]
|
Fig. 4C Hepatic metastasis on ferucarbotran-enhanced MRI in 65-year-old man.
Dynamic T1-weighted MR image (149/4.1; flip angle, 80°) obtained after
ferucarbotran injection shows clustered and hypointense lesions with rim
enhancements (arrow).
|
|

View larger version (112K):
[in a new window]
|
Fig. 4D Hepatic metastasis on ferucarbotran-enhanced MRI in 65-year-old man.
T2*-weighted MR image (149/10; flip angle, 30°) definitely
shows hyperintense lesion (arrow) that was interpreted as benign
lesion such as hepatic abscess. On follow-up CT 3 months later, diameter of
lesion and level of carcinoembryonic antigen were markedly increased. Lesion
was found to be metastasis.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2006 by the American Roentgen Ray Society.